Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn

NCT00243243 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20

Enrollment

FED

Sponsor class

Conditions

Burns

Interventions

DRUG: Recombinant Factor VIIa
DRUG: Placebo

Sponsor

United States Army Institute of Surgical Research